The global Milk Thistle Market is experiencing robust growth as consumer demand for natural, plant-based liver health solutions surges. Driven by heightened awareness of liver disorders, an expanding global wellness culture, and the rise of convenient delivery formats and e-commerce channels, the market is poised for steady expansion throughout the coming decade.

The global milk thistle market size was valued at USD 98.6 million in 2023 and is projected to grow from USD 105.3 million in 2024 to USD 176.1 million by 2031, exhibiting a CAGR of 7.63% during the forecast period.

Market snapshot — quick facts

• Leading application: Liver health.
• Largest regional share: Asia-Pacific.
• Key industry participants include: Indena S.p.A., Euromed S.A., LIVERD PHARMA, Panjin Shengbo, Bio Answer, Amway, NOW Foods, Nestlé Health Science, Jarrow Formulas, and others.

Executive summary

The milk thistle market is benefiting from a convergence of health trends: rising incidence and awareness of liver-related disorders, an aging global population seeking preventive supplements, and growing consumer preference for botanical and “clean label” wellness products. Milk thistle — prized for its silymarin complex and antioxidant, anti-inflammatory properties — is increasingly adopted in dietary supplements, functional foods, and clinical adjuncts for liver support. Manufacturers are responding with standardized extracts, new dosage forms (powders, gummies, liquids), and clinically oriented formulations to capture a wider audience.

Unlock Key Growth Opportunities: https://www.kingsresearch.com/milk-thistle-market-158

List of Key Companies in Milk Thistle Market

• Indena S.p.A.
• Euromed S.A
• LIVERD PHARMA CO., LTD.
• Panjin Shengbo Silymarin Extraction Co., Ltd.
• Bio Answer Holdings Inc
• Amway International Inc
• NOW Foods
• Inner Mongolia Ever Brilliance Biotechnology Co, Ltd
• Nestlé Health Science
• Jarrow Formulas, Inc.

Growth drivers

Market expansion is underpinned by several tangible drivers:

• Increased public awareness of liver health and the burden of liver diseases globally.
• Rising consumer preference for natural and plant-based remedies over synthetic pharmaceuticals.
• E-commerce proliferation, improving product discovery and accessibility for niche supplements.
• Product innovation: standardized silymarin extracts, combination formulas, and new convenient delivery formats that boost adoption among younger and convenience-oriented buyers.

Key growth factors:

• Rising incidence of liver ailments and greater screening/diagnosis rates.
• Aging population increasing demand for supportive nutraceuticals.
• Improved supply chains and cultivation/extraction capacity.
• Regulatory clarity encouraging retail adoption through pharmacies and healthcare channels.

Market dynamics — opportunities & challenges

Opportunities:

• Product standardization & clinical validation to command premium pricing and build trust.
• New consumer segments integrating milk thistle into wellness blends and beverages.
• Emerging markets with high herbal medicine acceptance.

Challenges:

• Lack of formulation standardization, causing variability and consumer uncertainty.
• Regulatory and claims scrutiny across regions.
• Competition from broader supplement portfolios, requiring differentiation.

Segmentation analysis

By application:

• Liver health — core therapeutic use case.
• Antioxidant support — growing adoption.
• Anti-inflammatory, skin health, and others — niche but expanding segments.

By distribution channel:

• Pharmacies — largest revenue share.
• Online retailers — fast expansion driven by convenience.
• Supermarkets, hospitals/clinics, and others — important for mainstream adoption.

By form:

• Capsules — traditional and widely used.
• Powder & granule — fastest-growing segment.
• Liquid and other novel formats (gummies, tinctures) — rising due to convenience.

Regional insights

Asia-Pacific leads due to herbal medicine acceptance and rising disposable incomes. Europe and North America remain key revenue centers supported by clinical validation and retailer networks. Latin America and MEA are emerging regions with expanding awareness and education-driven opportunities.

Regional highlights:

• Asia-Pacific: top share region with high adoption of herbal solutions.
• Europe: steady growth supported by established herbal supplement markets.
• North America: strong pharmacy presence and online channel maturity.

Strategic behaviors observed:

• Product innovation: combining milk thistle with complementary actives and user-friendly formats.
• Quality & standardization efforts: standardized silymarin content and third-party testing.
• Alliances & vertical integration: partnerships to guarantee supply reliability.

Recent developments highlight the launch of organic milk thistle gummies and combination formulations emphasizing product diversification.

Strategic recommendations

• Invest in clinical research and standardization for trust and premium positioning.
• Expand convenient formats such as powders, gummies, and liquids.
• Strengthen pharmacy and clinical relationships for physician and retailer endorsement.
• Focus on APAC expansion with tailored marketing and regulatory strategies.
• Differentiate via sustainability & traceability for eco-conscious consumers.

Closing comment

The milk thistle market is transitioning from a niche herbal remedy into a mainstream liver health and wellness ingredient. Market entrants prioritizing standardized formulations, clinical validation, modern consumer formats, and strategic regional focus will be best positioned to capture sustained growth in the coming years.